Paris—Four Dentons Life Sciences teams and seven lawyers individually have been distinguished by Chambers Europe 2014.

Dentons France and Russia are ranked band 1, while Dentons Poland is ranked band 3 and Dentons Germany is ranked band 4.

Lawyers Pascale Poupelin (France), Jean-Marc Grosperrin (France), François Vignaud (France), Alexander Skoblo (Russia), Wojciech Kozlowski (Poland) and Peter Homberg (Germany) have been distinguished individually.

This distinction is granted by Chambers Europe following extensive research including clients’ feedback supported by the submissions prepared by the teams detailing recent activity and interviews conducted during the course of research.

To qualify, firms have to demonstrate deep expertise and wide market presence. Individuals are assessed mainly on the positive feedback received from market sources.
 

Dentons France

Dentons France Pharma/Life Sciences Group – band 1 “Substantial team which covers all major practice areas and industries within healthcare and life sciences. Displays particular strength on corporate topics and M&A, acting on behalf of major players in this sector, in addition to significant expertise in dispute resolution and regulatory matters. Lawyers also assist domestic and international clients with IP, competition, distribution and contractual matters.” Clients say, “The service is consistently strong; the lawyers are always available, very proactive and they think of unique ways to solve problems” and “This team is very helpful and supportive; strong expertise, responsive and attuned to the needs of the client.”

Partner Pascale Poupelin – band 1 for both Pharma/Life Sciences product liability and regulatory.  “Practice co-head Pascale Poupelin comes highly recommended for her regulatory and litigation expertise and advises clients from the healthcare and pharmaceuticals sectors on various key topics. Clients note: “It was clear that she's a market-leading lawyer for litigation in pharmaceuticals. Her breadth of knowledge on the litigation landscape here was impressive.”

Partner Jean-Marc Grosperrin – band 3 for Pharma/Life Sciences corporate.
“Jean-Marc Grosperrin co-heads the Paris life sciences practice and focuses on corporate and M&A transactions, advising both French and foreign clients from the pharmaceutical and healthcare sectors. In the words of one client, “he's a really strong lawyer who is very direct and good to deal with. His advice is concise and practical, which is what I was looking for.”

Senior Counsel François Vignaud – band 1 for Pharma/Life Sciences corporate. “François Vignaud is best known for handling transactional matters. He also advises on regulatory and contractual work as well as pre-litigation. One happy client comments: “He was really helpful and proactive in providing us with advice. He also kept us up to speed on developments in France, which is very helpful when you don't have in-house counsel on the ground.”

Dentons Poland

Dentons Poland Pharma/Life Sciences Group – band 3 “Heavily involved in contentious cases such as product liability litigation, IP rights and patent disputes. Additional strength in reimbursement, regulatory and tax-related matters. Clients include pharmaceutical and biotechnology companies, medical device distributors and drug retailers.”

Partner Wojciech Kozłowski – band 3. “Wojciech Kozłowski is an expert litigator best known for handling healthcare mandates. Also recommended for regulatory matters.”

Dentons Germany

Dentons Germany Pharma/Life Sciences Group – band 4 “Expanding life sciences practice covering regulatory compliance, research and development agreements, IP licensing and transactions. Advises broad client base comprising biotechnology and pharmaceutical companies, as well as medical device manufacturers. Increasingly visible in transactional work. Ilka Diane Mehdorn recently arrived at the firm from WilmerHale, bringing with her a strong reputation for comprehensive advice to healthcare clients. Her wide-ranging expertise covers issues such as selective agreements, pharmaceutical law and litigation within the healthcare sector.”

Partner Peter Homberg– band 3. “Clients describe Peter Homberg as “a brilliant negotiator,” adding: "He has huge experience with biotech companies and is really goal driven. He understands our needs very well.” “He advises on a wide range of issues affecting biotechnology and pharmaceutical companies, with a focus on research and development agreements and licence agreements.”

About Dentons

Redefining possibilities. Together, everywhere. For more information visit dentons.com